L. Serrone

516 citations
7 papers · 411 indexed · h-index 4

L. Serrone

7 papers receiving 401 citations

Peers

L. Serrone
Comparison fields: 5 of 69
  • Oncology 209
  • Immunology 104
  • Molecular Biology 262
  • Immunology and Allergy 11
  • Dermatology 14
Replace Heike Helmbach with:
Heike Helmbach Germany
Bruno Gomes Canada
Jodie M. Borrow Australia
Samar N. Roy United States
Peter Koelblinger Austria
Koh Amano Japan
Motomu Shimizu Japan
Guo‐Liang Shen China
J C Kallestad United States
Gerard Bittner United States
L. Serrone relative to Heike Helmbach Germany Heike Helmbach's profile →
Citations per field
00.5×1.5×
Heike Helmbach · 1×
Citations per year

Countries citing papers authored by L. Serrone

Since Specialization
Citations

This map shows the geographic impact of L. Serrone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Serrone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Serrone more than expected).

Fields of papers citing papers by L. Serrone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Serrone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Serrone. The network helps show where L. Serrone may publish in the future.

Co-authorship network

The 18 scholars most cited alongside L. Serrone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with L. Serrone Line = papers co-authored together L. Serrone links everyone, so they are left out of the graph.

All Works

7 of 7 papers shown
#Work
1 20042
2 200111
3 20013
4
Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
2000269
5 1999117
6
13-cis retinoic acid and interferon alfa-2a in the treatment of metastatic renal cell carcinoma.
19986
7 19953

About L. Serrone

L. Serrone is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Hematology and Pathology and Forensic Medicine, having authored 7 papers that have together received 411 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (3 papers), Vascular Tumors and Angiosarcomas (2 papers), Click Chemistry and Applications (1 paper), Synthesis and biological activity (1 paper), Testicular diseases and treatments (1 paper), Bladder and Urothelial Cancer Treatments (1 paper), Brain Metastases and Treatment (1 paper) and Glioma Diagnosis and Treatment (1 paper). The work is most often cited by research in Oncology (209 citations), Immunology (104 citations), Molecular Biology (262 citations), Immunology and Allergy (11 citations) and Dermatology (14 citations). L. Serrone has collaborated with scholars based in Malaysia, India and Italy. Frequent co-authors include F. Cognetti, Massimo Zeuli, Peter Hersey, Teresa Gamucci, Marco Nardi, Massimiliano Casali, Umberto Pacetti, Francesco Cognetti, E. Terzoli and Silvia Carpano. Their work appears in journals such as Melanoma Research, Cancer Chemotherapy and Pharmacology, Journal of Clinical Oncology, European Journal of Cancer and Oncology Research and Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026